Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of phase III multicenter, double-blind, placebo-controlled trial - Johnson,K.P.; Brooks,B.R.; Cohen,J.A. (Neurology, 1995)